Stay updated with breaking news from Turn Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
MOUNTAIN VIEW, Calif., May 28, 2024 /PRNewswire/ -- Turn Biotechnologies, a developer of novel mRNA medicines and enabling technologies, today announced an
Synergistic collaboration to revolutionize age-related therapies worldwideDeal valued at over $300 million USD for initial product MOUNTAIN VIEW, Calif., May 28, 2024 /PRNewswire/ -- Turn Biotechnologies
/PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation developer of novel mRNA medicines for untreatable, age-related conditions, announced it is the first...
/PRNewswire/ -- Turn Biotechnologies, a cell rejuvenation developer of novel mRNA medicines for untreatable, age-related conditions, announced it is the first...